Improving arteriovenous fistula patency: Transdermal delivery of diclofenac reduces cannulation-dependent neointimal hyperplasia via AMPK activation

Creation of an autologous arteriovenous fistula (AVF) for vascular access in haemodialysis is the modality of choice. However neointimal hyperplasia and loss of the luminal compartment result in AVF patency rates of ~ 60% at 12 months. The exact cause of neointimal hyperplasia in the AVF is poorly u...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Vascul Pharmacol
Main Authors: MacAskill, Mark G., Watson, David G., Ewart, Marie-Ann, Wadsworth, Roger, Jackson, Andrew, Aitken, Emma, MacKenzie, Graeme, Kingsmore, David, Currie, Susan, Coats, Paul
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier Science 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534710/
https://ncbi.nlm.nih.gov/pubmed/25866325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vph.2015.02.012
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares